Prospective Sinonasal Cancer Multi-institution Study

NCT04755855 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-04-03

No results posted yet for this study

Summary

This is a multi-institution prospective study of patients with sinonasal malignancies. The goal of this study is to learn more about the course of sinonasal cancer, treatment outcomes, and patient quality of life. In addition, central mutational and genomic analysis of tumor tissue will be evaluated.

Conditions

  • Sinonasal Carcinoma

Sponsors & Collaborators

Principal Investigators

  • Jake Eide, MD · Mayo Clinic

Eligibility

Min Age
30 Days
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2031-01-31
Completion
2031-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04755855 on ClinicalTrials.gov